5 analysts have shared their evaluations of Medical Properties Trust MPW during the recent three months, expressing a mix of bullish and bearish perspectives.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 0 | 0 | 2 | 3 | 0 |
Last 30D | 0 | 0 | 1 | 0 | 0 |
1M Ago | 0 | 0 | 0 | 0 | 0 |
2M Ago | 0 | 0 | 1 | 1 | 0 |
3M Ago | 0 | 0 | 0 | 2 | 0 |
Analysts have recently evaluated Medical Properties Trust and provided 12-month price targets. The average target is $4.9, accompanied by a high estimate of $7.00 and a low estimate of $4.00. A decline of 45.56% from the prior average price target is evident in the current average.
Analyzing Analyst Ratings: A Detailed Breakdown
The analysis of recent analyst actions sheds light on the perception of Medical Properties Trust by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Vikram Malhotra | Mizuho | Lowers | Neutral | $7.00 | $9.00 |
Michael Lapides | JP Morgan | Lowers | Underweight | $5.00 | $8.00 |
Stephen Manaker | Stifel | Lowers | Hold | $4.50 | $12.00 |
Connor Siversky | Wells Fargo | Lowers | Underweight | $4.00 | $7.00 |
Connor Siversky | Wells Fargo | Announces | Underweight | $4.00 | - |
Key Insights:
- Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Medical Properties Trust. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Medical Properties Trust compared to the broader market.
- Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.
To gain a panoramic view of Medical Properties Trust's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
Stay up to date on Medical Properties Trust analyst ratings.
Unveiling the Story Behind Medical Properties Trust
Medical Properties Trust Inc is a healthcare facility REIT. The company operates one segment, which owns and leases healthcare facilities. The vast majority of Medical's revenue is generated in the United States, followed by Germany and the United Kingdom. The company considers merger and acquisition investment as a component of its operational growth strategy. It provides financing for a variety of facilities that require funds for acquisitions, sale-leasebacks, new developments, and expansion projects.
A Deep Dive into Medical Properties Trust's Financials
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Challenges: Medical Properties Trust's revenue growth over 3 months faced difficulties. As of 30 September, 2023, the company experienced a decline of approximately -12.99%. This indicates a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Real Estate sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 37.97%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Medical Properties Trust's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.4% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Medical Properties Trust's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 0.61%, the company showcases efficient use of assets and strong financial health.
Debt Management: Medical Properties Trust's debt-to-equity ratio is below the industry average. With a ratio of 1.24, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
Analyst Ratings: Simplified
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.